5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 100mg

1-(2,6-Difluorophenyl)ethylamine, 95.0%, 25g

ROTI® SampleLyse Soft Tissue 1, 10 pcs 10 pcs

4-[Bis(4-iodophenyl)amino]benzaldehyde>95.0%(GC)200mg

(2R,4R)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride, 95.0%, 10g

(2R,3R,4S,5R)-2-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97.0%, 50mg

N,N-Dimethyl-1-(morpholin-3-yl)methanamine, 95.0%, 1g

4-Fluoro-3-nitrobenzoic acid, 98.0%, 500g

N,N-Bis(2-hydroxyethyl)dodecanamide, 95.0%, 100g

5-(4-Fluorophenethylsulfonyl)-1-phenyl-1H-tetrazole, 95.0%, 250mg

6-bromo-5-methyl-3H,4H-thieno[2,3-d]pyrimidin-4-one, 1g

2-Methylpyridine-3-boronic acid hydrochloride, 95.0%, 250mg